The authors of the following paper "Endoplasmic Reticulum Ca^2+^ Release Causes Rieske Iron-Sulfur Protein-mediated Mitochondrial ROS Generation in Pulmonary Artery Smooth Muscle Cells" (*Bioscience Reports* (2019) 39(12) <https://doi.org/10.1042/BSR20192414>) would like to retract their paper. They have provided the following justification for retraction:

The results in the published paper indicated that mitochondrial ROS generation was increased by hypoxia treatment (see [Figure 4](#F4){ref-type="fig"}A). Inhibition of RyRs with tetracaine or genetic deletion of RyR2 attenuated hypoxia-induced ROS generation in mitochondria (see [Figure 4](#F4){ref-type="fig"}A,B). However, the authors have been unable to repeat the results in subsequent experiments, and their latest data have shown that deprivation of RyR2 is not able to attenuate hypoxia-induced ROS generation in mitochondria.

![Inhibition or genetic deletion of RyR2 blocks hypoxic ROS production in mitochondria of PASMCs\
(**A**) PASMCs were pretreated with tetracaine (1 μM) (C) for 5 min followed by hypoxia for 5 min. Mitochondrial ROS generation were measured using a Mitochondrial ROS Detection Assay Kit. \*\* P \< 0.01 compared with normoxia control group, and \#\#P \< 0.01 compared with hypoxia control group. (**B**) PASMCs from WT and RyR2 KO mice were exposed to normoxia or hypoxia for 5 min. Mitochondrial ROS were measured by a Mitochondrial ROS Detection Assay Kit. Data were obtained from 3 separate experiments. \*\*P \< 0.01 compared with control, and \#P \< 0.05; \#\#P \< 0.01 compared with WT group. (**C**) WT and RyR2 KO PASMCs were pretreated with 2-APB (20 μM) for 5 min followed by hypoxia for 5 min. Mitochondrial ROS generation were measured using a Mitochondrial ROS Detection Assay Kit. \*\* P \< 0.01 compared with normoxia control group, and \#\#P \< 0.01 compared with hypoxia control group group. (**D**) Cells were treated with Ru360 (1 μM) for 5 min, then exposed to caffeine (20 mM) for 5 min. mitochondrial ROS were measured by using a Mitochondrial ROS Detection Assay Kit. \*\* P \< 0.01; \*\*\* P \< 0.001 compared with normoxia control group, and \#\#P \< 0.01 compared with hypoxia control group. \[Ca^2+^\]~mito~ was determined by mitochondria-targeted double-mutated aequorin (pcDNA3.1+/mit-2mutAEQ). Ru360 (1 μM) decreased hypoxia-caused \[Ca^2+^\]~mito~. (**E**) RyR2 KO PASMCs were transfected with RyR2 overexpression plasmids. All groups were treated with hypoxia for 5 min. Mitochondrial ROS generation were measured using a Mitochondrial ROS Detection Assay Kit. \*\* P \< 0.01 compared with WT group, and \#P \< 0.05 compared with WT RyR2 KO group. (**F**) Mitochondrial ROS generation were measured using a Mitochondrial ROS Detection Assay Kit. \*\*P \< 0.01 compared with WT group, and \#P \< 0.05 compared with WT RyR2 KO group.](bsr-40-bsr20192414-g4){#F4}

All authors agree to the retraction, and apologise for any misunderstanding caused by their results.
